MMP13 is a critical target gene during the progression of osteoarthritis

Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis

(2011) Meina Wang et al.   Annals of the New York Academy of Sciences

Establishment of an index with increased sensitivity for assessing murine arthritis

(2011) Erik R. Sampson et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Smad1 plays an essential role in bone development and postnatal bone formation

(2011) M. Wang et al.   OSTEOARTHRITIS AND CARTILAGE

New molecular targets for the treatment of osteoarthritis

(2010) Maria José Alcaraz et al.   BIOCHEMICAL PHARMACOLOGY

Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases

(2010) Takayuki Shiomi et al.   PATHOLOGY INTERNATIONAL

Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development

(2009) C. B. Little et al.   ARTHRITIS AND RHEUMATISM

A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models

(2009) Vijaykumar M. Baragi et al.   ARTHRITIS AND RHEUMATISM

Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade

(2009) Marcela Hernández Ríos et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreERT2 transgenic mice

(2007) M. Zhu et al.   OSTEOARTHRITIS AND CARTILAGE